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Albumin Redhill, a variant human albumin, has been isolated by fast protein liquid chromatofocusing. The 
N-terminal sequence of this protein corresponded to that of albumin A except that one additional arginine 
residue was attached to the N-terminus. 
Variant albumin N-terminal sequence 
1. INTRODUCTION 
Bisalbuminemia, the presence in serum of 2 
albumins which have different electrophoretic 
mobilities, is well documented for humans [l]. 
Whilst many examples of bisalbuminemia have 
been reported [2], the structures and properties of 
the variant albumins have been little studied. The 
amino acid sequence of human albumin A (‘nor- 
mal’ albumin) has been determined by conven- 
tional sequencing techniques [3] and from the 
cDNA [4]. In addition, complete amino acid se- 
quences of 6 variant albumins [5-lo] and 2 partial 
sequences [ 1 l] have been reported. In 5 of the com- 
plete sequences, the mutations in the amino acid 
chains occur either at the N-terminus [5,8] or near 
the C-terminus [6,7,9]; only one mutation has been 
observed in the central region of the protein [lo]. 
The 2 albumins with variant N-termini are both 
proalbumins and hence each has a hexapeptide at- 
tached to the aspartic acid which is the N-terminal 
amino acid in albumin A. We now wish to report 
the determination of the N-terminal sequence of 
albumin Redhill, a variant albumin which we have 
recently isolated [ 121. 
2. MATERIALS AND METHODS 
Mixed albumin A and albumin Redhill was ob- 
tained from serum by precipitation with am- 
Arginine Chromatofocusing 
monium sulphate followed by chromatography on 
Sephadex G-100 as described [12]. Pure albumin 
Redhill was obtained from this mixture by fast 
protein liquid chromatography (chromatofocus- 
ing) using the Pharmacia FPLC system with a 
monoP HR 5120 column (Pharmacia, Milton 
Keynes, England). Aliquots (500~1) of a solution 
of the mixed albumins (lo-20 mg/ml) in 
piperazine.HCl buffer (25 mM, pH 6.3) were ap- 
plied to the monoP column which had already 
been equilibrated with this buffer. Elution of 
albumin Redhill was achieved at 1 ml/min with 
Polybuffer 74 diluted 1: 10 (v/v) in water (MilliQ, 
Millipore, England) which had been brought to pH 
4.5 with HCl. The fractions (-1 ml) were desalted 
on Sephadex G-25 columns (1 x 4 cm) and pro- 
teins detected by applying aliquots (10 ~1) onto a 
silica gel TLC plate, drying and spraying with a 
solution of 1-anilinonaphthalene-8-sulphonic acid 
(0.003% Mg’+ salt in aqueous 0.1 M potassium 
phosphate, pH 6.8). The presence of protein was 
indicated by fluorescence when the plate was ex- 
posed to radiation at 354 nm. The protein- 
containing fractions were pooled in 3 peaks, 
lyophilised and aliquots of the residue suspended 
in 37% aqueous sucrose (w/v) which contained 
bromophenol blue (0.01%) for analysis by non- 
denaturing, discontinuous polyacrylamide gel elec- 
trophoresis [ 131. 
The pooled fractions which contained ‘pure’ 
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albumin Redhill (>90% pure) were freed of 
Polybuffer by chromatography on Sephadex G-75 
(elution with 0.9% aqueous NaCl (w/v) when the 
albumin appeared in the first few fractions ahead 
of the Polybuffer. The protein-containing eluate 
was dialysed against distilled water and lyophi- 
lised. Samples of albumin Redhill (300 fig) were 
submitted for sequencing by an automated, solid- 
phase Edman method. The N-terminal sequence 
of albumin Redhill was Arg-Asp-Ala-His-Lys- 
Ser-Glu-Val-Ala-His-Arg-Phe-Lys-Asp-Leu. Our 
sample of albumin Redhill contained a trace of 
albumin A and the sequence of this protein was 
determined at the same time. The N-terminal 
sequence Asp-Ala-His-Lys-Ser-Glu-Val-Ala-His- 
Arg-Phe-Lys-Asp-Leu corresponded to that pre- 
viously published [3,4]. 
3. RESULTS AND DISCUSSION 
Mixed albumin A and albumin Redhill, when 
applied to the FPLC chromatofocusing column, 
eluted as 3 main peaks which were (in order of 
decreasing pH of eluant), albumin A, mixed 
albumins and albumin Redhill. The N-terminal 
amino acid of albumin Redhill had previously been 
shown to be arginine [12] and the partial sequence 
which we have now determined confirms this 
observation. Human proalbumin contains 2 
arginine residues adjacent to the N-terminal amino 
acid (aspartic acid) of albumin A [5]. The variant 
albumins Lille [8] and Christchurch [5] are pro- 
albumins in which one of these arginine residues 
has been replaced (fig.1) and it has been proposed 
[8] that mutation of this Arg-Arg sequence 
prevents cleavage of the N-terminal hexapeptide 
from proalbumin. In the case of albumin Redhill, 
-6 -5 -4 -3 -2 -1 1 2 3 4 
;a) Asp-Ala-His-Lys 
(b) Arg-Asp-Ala-His-Lys 
CC) Arg-Cly-Val-Phe-Arg-Arg-Asp-Ala-Hrs-Lys 
Cd) Arg-Cly-Val-Phe-Hm-Arg-Asp-Ala-His-Lys 
(e) Arg-Gly-Val-Phe-Arg-Gln-Asp-Ala-His-Lys 
Fig.1. N-terminal sequences of (a) albumin A [3,4], (b) 
albumin Redhill, (c) human proalbumin [S], (d) albumin 
Lille [8], (e) albumin Christchurch [5]. 
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cleavage of the proalbumin chain has probably oc- 
curred at the N-terminal side of the arginine 
residue at position - 1 (fig.1). If this is so it 
represents anew type of cleavage of the signal pep- 
tide of proalbumin. In this context it is of interest 
that a sample of bovine serum albumin has been 
observed which possesses an N-terminal arginine 
residue [14]. 
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